Ben Laidler & Charles Kantor on Global Markets and Magnificent 7 AI Investments

Global Market Opportunities

• 🌍 Ben Laidler suggests that the rest of the world presents a better risk-reward proposition than the US currently.
• 📈 Growth is firming up globally, interest rates are being cut, and fiscal stimulus is present, making international markets attractive.
• 💰 Currencies and valuations are cheap abroad, and the US market is so supersized that even a small amount of capital can drive significant outperformance elsewhere.
• 🇧🇷 Laidler expressed particular enthusiasm for Brazil, noting it is incredibly inexpensive.

Magnificent 7: R&D and Capex Prowess

• 💡 Charles Kantor highlights the significant investments made by the Magnificent 7 companies in R&D and capital expenditures.
• 🔬 These seven companies collectively spend over 9% of their revenues on R&D, exceeding $250 billion annually, which is more than the entire healthcare and biotech sectors combined.
• 🏗️ In terms of capital expenditures, especially for AI investments, the Magnificent 7 spent more last year than the entire materials, mining, and industrial sectors combined.
• 🚀 This substantial investment in R&D and capex gives these companies incredible optionality on the future.

Market Outlook and Inflation

• 🇺🇸 While not advocating to sell US assets, Laidler positions the US market as an average 10% environment.
• 📊 The week ahead is marked by a key inflation report scheduled for Wednesday.